81.15
0.51%
-0.42
After Hours:
81.15
Hologic Inc stock is traded at $81.15, with a volume of 1.36M.
It is down -0.51% in the last 24 hours and down -0.29% over the past month.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
See More
Previous Close:
$81.57
Open:
$81.18
24h Volume:
1.36M
Relative Volume:
0.93
Market Cap:
$18.94B
Revenue:
$3.99B
Net Income/Loss:
$701.50M
P/E Ratio:
42.05
EPS:
1.93
Net Cash Flow:
$1.01B
1W Performance:
-0.58%
1M Performance:
-0.29%
6M Performance:
+7.65%
1Y Performance:
+19.67%
Hologic Inc Stock (HOLX) Company Profile
Name
Hologic Inc
Sector
Industry
Phone
(508) 263-2900
Address
250 CAMPUS DRIVE, MARLBOROUGH, MA
Hologic Inc Stock (HOLX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-01-24 | Downgrade | Citigroup | Buy → Neutral |
Jun-27-24 | Initiated | Stephens | Overweight |
Apr-03-24 | Upgrade | Citigroup | Neutral → Buy |
Jul-14-23 | Upgrade | Needham | Hold → Buy |
Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
Oct-13-22 | Initiated | Mizuho | Buy |
Jul-20-22 | Downgrade | BofA Securities | Buy → Neutral |
Jul-20-22 | Initiated | UBS | Neutral |
Jul-18-22 | Downgrade | BTIG Research | Buy → Neutral |
Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Apr-04-22 | Downgrade | Evercore ISI | Outperform → In-line |
Dec-15-21 | Downgrade | Citigroup | Buy → Neutral |
Oct-15-21 | Resumed | Cowen | Outperform |
Oct-14-21 | Initiated | Redburn | Neutral |
Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
Nov-20-20 | Downgrade | Needham | Buy → Hold |
Nov-05-20 | Reiterated | Needham | Buy |
Jun-30-20 | Upgrade | Cowen | Market Perform → Outperform |
Jun-03-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
Apr-30-20 | Reiterated | Needham | Buy |
Apr-30-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
Apr-07-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Mar-27-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
Jan-13-20 | Reiterated | Needham | Buy |
Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
Jan-07-20 | Initiated | Citigroup | Buy |
Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
Aug-01-19 | Reiterated | Needham | Buy |
May-02-19 | Reiterated | Needham | Buy |
Jan-31-19 | Reiterated | Needham | Buy |
Jan-02-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
Oct-09-18 | Initiated | UBS | Neutral |
Sep-13-18 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Hologic Inc Stock (HOLX) Latest News
Hologic (HOLX) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance
Hologic to close CT facility and lay off 86 workers that make women's health products by February - CT Insider
Women’s health tech company to lay off 71 employees at Danbury facility - Hartford Business Journal
Hologic to acquire Gynesonics - MSN
Radiology Information Systems Global Market is Projected - openPR
Hologic Inc. stock outperforms competitors on strong trading day - MarketWatch
Claro Advisors LLC Has $2.24 Million Stock Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic, KKR-backed Ajax Health develop lung cancer detection platform - MSN
Hologic (NASDAQ:HOLX) Seems To Use Debt Rather Sparingly - Simply Wall St
HIV Diagnostics Test Market Forecast for Robust Growth - openPR
Hologic, Inc. (NASDAQ:HOLX) Sees Significant Growth in Short Interest - MarketBeat
Hologic Inc. stock rises Wednesday, still underperforms market - MarketWatch
There is a ‘disparity’ in how we treat men and women’s health issues: Steve MacMillan - Fox Business
Exchange Traded Concepts LLC Buys 8,416 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic to acquire developer of ultrasound imaging device for $350M - Radiology Business
Hologic (HOLX) Gains As Market Dips: What You Should Know - Yahoo Finance
Swedbank AB Raises Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic to acquire Gynesonics in $350M deal - Mass Device
Hologic to buy Gynesonics for $350M to acquire fibroid system - MedTech Dive
Hologic to acquire Gynesonics for $350 million - DOTmed
Hologic to acquire maker of uterine fibroid device for $350M - The Business Journals
Hologic's (HOLX) "Buy" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Hologic to Buy Gynesonics - FinSMEs
Hologic to acquire Gynesonics to strengthen women’s health portfolio - Medical Device Network
Hologic to acquire Gynesonics for USD 350 million - Medical Buyer
Asia Cervical Cancer Screening Market Forecast Report 2024-2032, Featuring Profiles of Abbott Laboratories, Hologic, Becton, Siemens, Roche Diagnostics, Quest Diagnostics and Cardinal Health - Yahoo Finance
Hologic buys developer of minimally invasive solutions for women’s health Gynesonics for $350 M - BSA bureau
Hologic to acquire Gynesonics, developer of minimally invasive solutions for women’s health for $350 M - BSA bureau
Hologic maintains $90 target with Gynesonics acquisition - Investing.com
Hologic to Acquire Gynesonics - citybiz
Hologic to acquire Gynesonics for $350M - BioWorld Online
Hologic maintains $90 target with Gynesonics acquisition By Investing.com - Investing.com UK
Hologic To Acquire Gynesonics - MPO-mag
Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments - Yahoo Finance
Wedge Capital Management L L P NC Reduces Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic up on Gynesonics acquisition - XM
Female Sterilization Procedures Market 2024-2031 | Company - openPR
Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health - Milton Daily Standard
Biopsy Devices Market Industry Insights: Market Size, Share, - openPR
Here's How Much $100 Invested In Hologic 20 Years Ago Would Be Worth Today - Quantisnow
Clostridium Difficile Immunoassays Global Market Report |Hologic Inc., TECHLAB, Inc., Roche AG, Merck & Co., Pfizer, Inc – IndiaPolitics.com - IndiaPolitics.com
Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)? - Yahoo Finance
HOLX Launches BustTheMyth Campaign for Breast Health Awareness - MSN
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock - Yahoo Finance
Sanctuary Advisors LLC Acquires New Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Digital Breast Tomosynthesis Equipment Market 2024-2031 - openPR
Leerink Partnrs Equities Analysts Cut Earnings Estimates for Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Clinical Diagnostic Market Growth Drivers, Opportunities, - openPR
Hologic Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Will Hologic (HOLX) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Should You Bet on HOLX Stock This Breast Cancer Awareness Month? - Yahoo Finance
Hologic Inc Stock (HOLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):